|
|
 |
 |
| PDB id |
 |
Count |
 |
Name |
 |
Method |
 |
Date |
 |
|
|
|
×0
|
|
A beta-hairpin mimic from fceri-alpha-cyclo(rd-262)
|
|
NMR(15 models)
|
|
25-Aug-99
|
|
|
|
×0
|
|
Nmr structure of an engineered contryphan cyclic peptide (motif cpxxpxc)
|
|
NMR(20 models)
|
|
13-Sep-00
|
|
|
|
×7
|
|
Crystal structure of the tyrosine-regulated 3-deoxy-d-arabino- heptulosonate-7-phosphate synthase from saccharomyces cerevisiae complexed with tyrosine and manganese
|
|
X-ray(2.1Å)
|
|
06-May-04
|
|
|
|
×4
|
|
Crystal structure of a d,l-alternating peptide
|
|
X-ray(1.4Å)
|
|
24-Sep-04
|
|
|
|
×1
|
|
Crystal structure of mcsg target apc35536 from bacillus stearothermophilus
|
|
X-ray(2.8Å)
|
|
05-Oct-04
|
|
|
|
×0
|
|
Structure of the anti-cholera toxin antibody fab fragment te33 in complex with a d-peptide
|
|
X-ray(1.78Å)
|
|
04-Apr-06
|
|
|
|
×0
|
|
Crystal structure of fxa/selectide/napc2 ternary complex
|
|
X-ray(2.2Å)
|
|
13-Feb-07
|
|
|
|
×0
|
|
Nmr structure of the sterol-dependent antifungal antibiotic bacillomycin lc
|
|
NMR(19 models)
|
|
03-Oct-06
|
|
|
|
×0
|
|
Nmr structure determination of a synthetic analogue of the iturinic antibiotic bacillomycin lc
|
|
NMR(31 models)
|
|
03-Oct-06
|
|
|
|
×0
|
|
Trn- peptide of the two-component bacteriocin thuricin cd
|
|
NMR(20 models)
|
|
11-Jan-12
|
|
|
|
×2
|
|
Crystal structure of all-d monellin at 1.8 a resolution
|
|
X-ray(1.8Å)
|
|
13-Nov-07
|
|
|
|
×2
|
|
Structure of the gp41 n-trimer in complex with the HIV entry inhibitor pie7
|
|
X-ray(2Å)
|
|
02-Oct-07
|
|
|
|
×2
|
|
Structure of the gp41 n-trimer in complex with the HIV entry inhibitor pie7
|
|
X-ray(1.66Å)
|
|
02-Oct-07
|
|
|
|
×0
|
|
A beta-hairpin mimic from fceri-alpha-cyclo(rd-262)
|
|
NMR(15 models)
|
|
22-Feb-99
|
|
|
|
×0
|
|
Structural basis of salmonella typhi type ivb pils and cystic fibrosis transmembrane conductance regulator (cftr) interaction
|
|
X-ray(1.9Å)
|
|
27-Oct-09
|
|
|
|
×3
|
|
Crystal structure of d-enantiomer of human alpha-defensin 1 (d-hnp1)
|
|
X-ray(1.56Å)
|
|
28-Jul-09
|
|
|
|
×2
|
|
Pie12 d-peptide against HIV entry
|
|
X-ray(1.55Å)
|
|
03-Nov-10
|
|
|
|
×0
|
|
Pie12 d-peptide against HIV entry
|
|
X-ray(1.45Å)
|
|
03-Nov-10
|
|
|
|
×0
|
|
Pie12 d-peptide against HIV entry
|
|
X-ray(1.45Å)
|
|
03-Nov-10
|
|
|
|
×2
|
|
Crystal structure of human mdm2 in complex with d-peptide inhibitor (dpmi-alpha)
|
|
X-ray(2.4Å)
|
|
09-Mar-10
|
|
|
|
×3
|
|
New strategy to analyze structures of glycopeptide-target complexes
|
|
X-ray(2.5Å)
|
|
06-Jun-12
|
|
|
|
×2
|
|
Crystal structure of human mdm2 in complex with a trifluoromethylated d-peptide inhibitor
|
|
X-ray(1.8Å)
|
|
20-Jun-12
|
|
|
|
×0
|
|
X-ray crystal structure of a novel topological analogue of crambin
|
|
X-ray(1.08Å)
|
|
08-Feb-12
|
|
|
|
×3
|
|
Crystal structure of chemically synthesized heterochiral {d-protein antagonist plus vegf-a} protein complex in space group p21/n
|
|
X-ray(1.6Å)
|
|
05-Sep-12
|
|
|
|
×10
|
|
Crystal structure of chemically synthesized heterochiral {d-protein antagonist plus vegf-a} protein complex in space group p21
|
|
X-ray(1.6Å)
|
|
05-Sep-12
|
|
|
|
×20
|
|
Crystal structure of the mirror image form of vegf-a
|
|
X-ray(1.9Å)
|
|
05-Sep-12
|
|
|
|
×1
|
|
X-ray crystal structure of racemic non-glycosylated chemokine ser-ccl1
|
|
X-ray(2Å)
|
|
07-May-14
|
|
|
|
×1
|
|
(Quasi-)racemic x-ray crystal structure of glycosylated chemokine ser- ccl1.
|
|
X-ray(2.1Å)
|
|
07-May-14
|
|
|
|
×1
|
|
3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from mycobacterium tuberculosis with d-tyrosine bound in the phenylalanine binding site
|
|
X-ray(2.05Å)
|
|
01-Jun-16
|
|
|
|
×2
|
|
3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from mycobacterium tuberculosis with d-tyrosine bound in the tyrosine and phenylalanine binding sites
|
|
X-ray(2.05Å)
|
|
01-Jun-16
|
|
|
|
×3
|
|
Quasi-racemic snakin-1 in p1 after radiation damage
|
|
X-ray(1.57Å)
|
|
18-May-16
|
|
|
|
×3
|
|
Quasi-racemic snakin-1 in p1 before radiation damage
|
|
X-ray(1.51Å)
|
|
18-May-16
|
|
|
|
×0
|
|
Linear tri-ubiquitin
|
|
X-ray(1.8Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Linear tetra-ubiquitin
|
|
X-ray(2.21Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys6-linked di-ubiquitin
|
|
X-ray(1.15Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys11-linked diubiquitin
|
|
X-ray(1.73Å)
|
|
02-Nov-16
|
|
|
|
×1
|
|
Lys27-linked di-ubiquitin
|
|
X-ray(1.15Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys29-linked di-ubiquitin
|
|
X-ray(1.98Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys33-linked di-ubiquitin
|
|
X-ray(1.95Å)
|
|
02-Nov-16
|
|
|
|
×1
|
|
Lys48-linked di-ubiquitin
|
|
X-ray(1.59Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys63-linked di-ubiquitin
|
|
X-ray(1.55Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
K11/k63-branched tri-ubiquitin
|
|
X-ray(1.84Å)
|
|
02-Nov-16
|
|
|
|
×3
|
|
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21/n
|
|
X-ray(2.1Å)
|
|
09-Mar-16
|
|
|
|
×11
|
|
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21
|
|
X-ray(2.1Å)
|
|
09-Mar-16
|
|
|
|
×0
|
|
Quasi racemic structure of allo-ile7-shk and d-shk
|
|
X-ray(1.2Å)
|
|
25-Jan-17
|
|
|
|
×0
|
|
Quasi racemic structure of allo-thr13-shk and d-shk
|
|
X-ray(0.9Å)
|
|
25-Jan-17
|
|
|
|
×0
|
|
Lys27-linked diubiquitin
|
|
X-ray(1.55Å)
|
|
18-May-16
|
|
|
|
×0
|
|
Lys27-linked triubiquitin
|
|
X-ray(2.1Å)
|
|
18-May-16
|
|
|
|
×2
|
|
Lys27-linked triubiquitin
|
|
X-ray(1.99Å)
|
|
20-Jul-16
|
|
|
|
×0
|
|
Selective and potent inhibition of the glycosidase human amylase by the short and extremely compact peptide piha from mRNA display
|
|
X-ray(1.83Å)
|
|
29-Mar-17
|
|
|
|
×1
|
|
1.95a resolution structure of independent phosphoglycerate mutase from c. Elegans in complex with a macrocyclic peptide inhibitor (2d)
|
|
X-ray(1.95Å)
|
|
05-Apr-17
|
|
|
|
×0
|
|
Jmjd2a/ kdm4a complexed with ni(ii) and macrocyclic peptide inhibitor cp2 (13-mer)
|
|
X-ray(2.5Å)
|
|
12-Apr-17
|
|
|
|
×1
|
|
Jmjd2a/ kdm4a complexed with ni(ii), nog and macrocyclic peptide inhibitor cp2_r6kme3 (13-mer)
|
|
X-ray(2.43Å)
|
|
12-Apr-17
|
|
|
|
×0
|
|
Bicyclic antimicrobial peptides
|
|
X-ray(1.17Å)
|
|
23-Aug-17
|
|
|
|
×0
|
|
Crystal structure of p-ub-s65-nh2
|
|
X-ray(1.82Å)
|
|
05-Apr-17
|
|
|
|
×0
|
|
Crystal structure of p-diub-s65-cooh
|
|
X-ray(2.19Å)
|
|
12-Apr-17
|
|
|
|
×0
|
|
K11/48-branched teraubiquitin
|
|
X-ray(2.38Å)
|
|
19-Apr-17
|
|
|
|
×0
|
|
Crystal structure of ubiquitin-k6mimic
|
|
X-ray(2.27Å)
|
|
19-Jul-17
|
|
|
|
×0
|
|
Solution structure of de novo macrocycle design11_ss
|
|
NMR(20 models)
|
|
27-Dec-17
|
|
|
|
×0
|
|
Chimeric rat c5a
|
|
X-ray(1.31Å)
|
|
22-Apr-20
|
|
|
|
×0
|
|
Racemic x-ray structure of calcicludine
|
|
X-ray(2.52Å)
|
|
06-Nov-19
|
|
|
|
×0
|
|
Macrocyclization of an all-d linear peptide improves target affinity and imparts cellular activity: a novel stapled alpha-helical peptide modality
|
|
X-ray(1.79Å)
|
|
16-Oct-19
|
|
|
|
×1
|
|
Human coagulation factor xiia (fxiia) bound with the macrocyclic peptide f3 containing two (1s,2s)-2-achc residues
|
|
X-ray(3Å)
|
|
02-Sep-20
|
|
|
|
×0
|
|
Crystal structure of the nod sirpa complex with d4-2
|
|
X-ray(1.36Å)
|
|
01-Jul-20
|
|
|
|
×0
|
|
Crystal structure of glucagon analog fully composed of d-amino acids in space group i41 at 1.1 a resolution
|
|
X-ray(1.1Å)
|
|
01-Jul-20
|
|
|
|
×0
|
|
Crystal structure of glucagon analog composed of d-amino acids with mono-stereoinversion at position 23 (l-val23) in space group i41 at 1.33 a resolution
|
|
X-ray(1.33Å)
|
|
01-Jul-20
|
|
|
|
×0
|
|
Crystal structure of glucagon analog fully composed of d-amino acids with 4-bromo-d-phenylalanine substitutions at position 6 and 22 in space group i41 at 1.1 a resolution
|
|
X-ray(1.32Å)
|
|
01-Jul-20
|
|
|
|
×0
|
|
Pie12 d-peptide against HIV entry (in complex with iqn17 q577r resistance mutant)
|
|
X-ray(1.3Å)
|
|
05-Feb-20
|
|
|
|
×0
|
|
Structure of fucosylated d-antimicrobial peptide sb5 in complex with the fucose-binding lectin pa-iil at 1.438 angstrom resolution
|
|
X-ray(1.44Å)
|
|
20-Mar-19
|
|
|
|
×3
|
|
Structure of fucosylated d-antimicrobial peptide sb6 in complex with the fucose-binding lectin pa-iil at 1.525 angstrom resolution
|
|
X-ray(1.53Å)
|
|
20-Mar-19
|
|
|
|
×3
|
|
Structure of fucosylated d-antimicrobial peptide sb4 in complex with the fucose-binding lectin pa-iil at 2.009 angstrom resolution
|
|
X-ray(2.01Å)
|
|
20-Mar-19
|
|
|
|
×3
|
|
Structure of fucosylated d-antimicrobial peptide sb11 in complex with the fucose-binding lectin pa-iil at 1.990 angstrom resolution
|
|
X-ray(1.99Å)
|
|
20-Mar-19
|
|
|
|
×1
|
|
Structure of fucosylated d-antimicrobial peptide sb4 in complex with the fucose-binding lectin pa-iil at 2.008 angstrom resolution
|
|
X-ray(2.01Å)
|
|
20-Mar-19
|
|
|
|
×0
|
|
Structure of fucosylated d-antimicrobial peptide sb10 in complex with the fucose-binding lectin pa-iil at 2.541 angstrom resolution
|
|
X-ray(2.54Å)
|
|
20-Mar-19
|
|
|
|
×1
|
|
Structure of fucosylated d-antimicrobial peptide sb10 in complex with the fucose-binding lectin pa-iil at 1.707 angstrom resolution
|
|
X-ray(1.71Å)
|
|
20-Mar-19
|
|
|
|
×0
|
|
Cfucosylated second generation peptide dendrimer sbd6 bound to fucose binding lectin lecb (pa-iil) from pseudomonas aeruginosa at 2.08 angstrom resolution, incomplete structure
|
|
X-ray(2.08Å)
|
|
21-Aug-19
|
|
|
|
×2
|
|
Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2
|
|
X-ray(1.6Å)
|
|
14-Oct-20
|
|
|
|
×0
|
|
Crystal structure of human vps29 complexed with rapid-derived cyclic peptide rt-d1
|
|
X-ray(2.01Å)
|
|
14-Jul-21
|
|
|
|
×0
|
|
Crystal structure of human vps29 complexed with rapid-derived cyclic peptide rt-d2
|
|
X-ray(1.58Å)
|
|
14-Jul-21
|
|
|
|
×0
|
|
Crystal structure of chaetomium thermophilum vps29 complexed with rapid-derived cyclic peptide rt-d3
|
|
X-ray(1.95Å)
|
|
14-Jul-21
|
|
|
|
×1
|
|
Fucosylated antimicrobial linear peptide cfucrh46d in complex with the fucose binding lectin lecb from pseudomonas aeruginosa at 2.1 angstrom resolution
|
|
X-ray(2.06Å)
|
|
17-Feb-21
|
|
|
|
×7
|
|
Fucosylated antimicrobial peptide sb6 in complex with the lectin lecrsl from ralstonia solanacearum at 2.4 angstrom resolution
|
|
X-ray(2.43Å)
|
|
17-Feb-21
|
|
|
|
×0
|
|
Hif prolyl hydroxylase 2 (phd2/ egln1) in complex with 2og and rapid- derived silent allosteric cyclic peptide 3c (14-mer)
|
|
X-ray(1.46Å)
|
|
30-Dec-20
|
|
|
|
×0
|
|
Hif prolyl hydroxylase 2 (phd2/ egln1) in complex with bicyclic fg2216 and rapid-derived cyclic peptide 3c (14-mer)
|
|
X-ray(2.14Å)
|
|
30-Dec-20
|
|
|
|
×0
|
|
Hif prolyl hydroxylase 2 (phd2/ egln1) in complex with n-oxalyl glycine (nog), hif-1alpha codd (556-574) and a rapid-derived cyclic peptide 3c (14-mer)
|
|
X-ray(2.28Å)
|
|
30-Dec-20
|
|
|
|
×0
|
|
Hif prolyl hydroxylase 2 (phd2/ egln1) in complex with n-oxalylglycine (nog) and a rapid-derived silent allosteric cyclic peptide 3c (14- mer)
|
|
X-ray(1.53Å)
|
|
30-Dec-20
|
|
|
|
×0
|
|
C3b in complex with cp40
|
|
X-ray(2Å)
|
|
12-Jan-22
|
|
|
|
×0
|
|
Crystal structure of gppnhp-bound gnas in complex with the cyclic peptide inhibitor gn13
|
|
X-ray(1.57Å)
|
|
31-Mar-21
|
|
|
|
×3
|
|
Crystal structure of gdp-bound gnas in complex with the cyclic peptide inhibitor gd20
|
|
X-ray(1.95Å)
|
|
02-Mar-22
|
|
|
|
×1
|
|
Crystal structure of human mdm2 in complex with d-peptide inhibitor (dpmi-omega)
|
|
X-ray(1.4Å)
|
|
17-Nov-21
|
|
|
|
×1
|
|
Crystal structure of human mdmx in complex with d-peptide inhibitor (dpmi-omega)
|
|
X-ray(2.8Å)
|
|
17-Nov-21
|
|
|
|
×1
|
|
1.80a resolution structure of independent phosphoglycerate mutase from c. Elegans in complex with a macrocyclic peptide inhibitor (ce-1 nhoh)
|
|
X-ray(1.8Å)
|
|
07-Apr-21
|
|
|
|
×1
|
|
2.10a resolution structure of independent phosphoglycerate mutase from c. Elegans in complex with a macrocyclic peptide inhibitor (ce-2 y7f)
|
|
X-ray(2.1Å)
|
|
07-Apr-21
|
|
|
|
×4
|
|
Structure of sars-cov-2 spike rbd in complex with cyclic peptide
|
|
X-ray(3.96Å)
|
|
30-Jun-21
|
|
|
|
×1
|
|
D-protein rfx-v1 bound to the vegfr1 domain 2 site on vegf-a
|
|
X-ray(2.31Å)
|
|
17-Feb-21
|
|
|
|
×3
|
|
D-protein rfx-v2 bound to the vegfr1 domain 3 site on vegf-a
|
|
X-ray(2.9Å)
|
|
03-Mar-21
|
|
|
|
×0
|
|
Hyen d
|
|
X-ray(1.35Å)
|
|
22-Sep-21
|
|
|
|
×0
|
|
[I11g]hyen d
|
|
X-ray(1.3Å)
|
|
22-Sep-21
|
|
|
|
×0
|
|
Crystal structure of cycloviolacin o2
|
|
X-ray(1.17Å)
|
|
22-Sep-21
|
|
|
|
×0
|
|
Crystal structure of [i11l]cycloviolacin o2
|
|
X-ray(1.04Å)
|
|
22-Sep-21
|
 |
');
}
//
// Otherwise, show static image
//
else
{
//
// Show static image
//
document.getElementById('gldiv').innerHTML
= '
';
//
// Remove 3Dmol icon and comment
//
if (document.getElementById('3dicon'))
{
document.getElementById('3dicon').innerHTML = '';
}
if (document.getElementById('use_mouse'))
{
document.getElementById('use_mouse').innerHTML = '';
}
}
